{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:13:53Z","timestamp":1789096433993,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health PGRN","doi-asserted-by":"publisher","award":["DA020830"],"award-info":[{"award-number":["DA020830"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Research Chair in Pharmacogenomics, Canadian Institutes of Health Research","award":["FDN-154294"],"award-info":[{"award-number":["FDN-154294"]}]},{"name":"Canada Research Chair in Pharmacogenomics, Canadian Institutes of Health Research","award":["PJT-153286"],"award-info":[{"award-number":["PJT-153286"]}]},{"name":"Centre for Addiction and Mental Health and the CAMH Foundation; the Canada Foundation for Innovation","award":["20289"],"award-info":[{"award-number":["20289"]}]},{"name":"Centre for Addiction and Mental Health and the CAMH Foundation; the Canada Foundation for Innovation","award":["16014"],"award-info":[{"award-number":["16014"]}]},{"name":"Ontario Ministry of Research and Innovation"},{"name":"Global Research Awards for Nicotine Dependence (GRAND)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.drugalcdep.2018.04.035","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T22:00:25Z","timestamp":1530050425000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes"],"prefix":"10.1016","volume":"190","author":[{"given":"Annie R.","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schnoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Larry W.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cinciripini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony P.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ADM.0b013e31829363e1","article-title":"The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence","volume":"7","author":"Ashare","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/aje\/kwn301","article-title":"Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial\/ethnic groups in the United States between 1999 and 2004","volume":"169","author":"Benowitz","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0015","series-title":"Enhancing Medication Adherence: The Public Health Dilemma","author":"Bosworth","year":"2012"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0020","series-title":"Patient Treatment Adherence: Concepts, Interventions, and Measurement","author":"Bosworth","year":"2006"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","article-title":"Reliability and validity of a smoking timeline follow-back interview","volume":"12","author":"Brown","year":"1998","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0030","first-page":"Cd009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntr003","article-title":"Adherence to varenicline in the COMPASS smoking cessation intervention trial","volume":"13","author":"Catz","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ntr\/ntv125","article-title":"The nicotine metabolite ratio is associated with early smoking abstinence even after controlling for factors that influence the nicotine metabolite ratio","volume":"18","author":"Chenoweth","year":"2016","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5127\/jep.008310","article-title":"Best practices for using median splits, artificial categorization, and their continuous alternatives","volume":"2","author":"DeCoster","year":"2011","journal-title":"J. Exp. Psychopathol."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0055","series-title":"Handbook of Behavioral Medicine.","article-title":"Adherence to medical advice: processes and measurement","author":"Dunbar-Jacob","year":"2010"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cmaj.070256","article-title":"Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials","volume":"179","author":"Eisenberg","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0065","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/0091270006290669","article-title":"Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers","volume":"46","author":"Faessel","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","article-title":"A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation","volume":"49","author":"Faessel","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0075","first-page":"627","article-title":"Receiver Operating Characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Casp. J. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ntr\/ntq047","article-title":"Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence","volume":"12","author":"Hays","year":"2010","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0920-1211(90)90090-I","article-title":"Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy","volume":"6","author":"Herkes","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0090","first-page":"Cd009164","article-title":"Interventions to increase adherence to medications for tobacco dependence","volume":"2","author":"Hollands","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2010.12.012","volume":"879","author":"Jacob","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1360-0443.2004.00957.x","article-title":"Cut-off levels for breath carbon monoxide as a marker for cigarette smoking","volume":"100","author":"Javors","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0105","series-title":"Disease Control Priorities in Developing Countries","article-title":"Tobacco addiction","author":"Jha","year":"2006"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0110","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.18553\/jmcp.2013.19.2.125","article-title":"Adherence to varenicline and associated smoking cessation in a community-based patient setting","volume":"19","author":"Liberman","year":"2013","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0125","first-page":"Cd000011","article-title":"Interventions for enhancing medication adherence","volume":"11","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12160-013-9510-x","article-title":"Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial","volume":"46","author":"Nollen","year":"2013","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10985-012-9238-0","article-title":"Understanding increments in model performance metrics","volume":"19","author":"Pencina","year":"2013","journal-title":"Lifetime Data Anal."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addbeh.2017.11.032","article-title":"Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: a commentary on Peng, et al. 2017","volume":"79","author":"Peng","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addbeh.2017.07.006","article-title":"Measures and predictors of varenicline adherence in the treatment of nicotine dependence","volume":"75","author":"Peng","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/bdd.728","article-title":"The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results","volume":"31","author":"Ruiz","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0160","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabat\u00e9","year":"2003"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0165","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00213-013-3421-1","article-title":"The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race","volume":"231","author":"Schnoll","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0170","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1360-0443.2007.01791.x","article-title":"Use of more nicotine lozenges leads to better success in quitting smoking","volume":"102","author":"Shiffman","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0175","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.clinthera.2008.09.016","article-title":"Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers","volume":"30","author":"Shiffman","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0180","first-page":"203","article-title":"Measures of diagnostic accuracy: basic definitions","volume":"19","author":"Simundic","year":"2009","journal-title":"EJIFCC"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ntr\/ntp187","article-title":"Disparities in tobacco cessation medication orders and fills among special populations","volume":"12","author":"Solberg","year":"2010","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation","volume":"4","author":"SRNT Subcomittee on Biochemical Verification","year":"2002","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0195","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/1055-9965.EPI-12-0236","article-title":"Reproducibility of the nicotine metabolite ratio in cigarette smokers","volume":"21","author":"St Helen","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0200","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1055-9965.EPI-14-1381","article-title":"Nicotine metabolite ratio (3-hydroxycotinine\/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation","volume":"24","author":"Tanner","year":"2015","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0205","series-title":"The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services (USDHHS)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6963-7-55","article-title":"Patient adherence to medical treatment: a review of reviews","volume":"7","author":"van Dulmen","year":"2007","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: Three decades of research. A comprehensive review","volume":"26","author":"Vermeire","year":"2001","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.drugalcdep.2018.04.035_bib0220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/clpt.2012.186","article-title":"CYP2B6 and bupropion\u2019s smoking-cessation pharmacology: the role of hydroxybupropion","volume":"92","author":"Zhu","year":"2012","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618303089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618303089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T12:46:37Z","timestamp":1661517997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618303089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":44,"alternative-id":["S0376871618303089"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}